PGEN
PGEN's valuation appears fair while fundamentals provide solid support and forward estimates point to a return to profit and improving margins, though analyst coverage is limited and estimates vary widely.
PGEN vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 8.4x | 14x | 42% lower-42% |
| PE percentile | 5.9 | 51 | 88% lower-88% |
| EPS | -$1.14 | -$0.66 | $0.49 lower-$0.49 |
| FCF | -$115.8M | -$74.3M | -$41.5M-$41.5M |
| Loading historical comparisons… | |||
PGEN’s earnings are below their historical averages, while its earnings multiple is lower.
PGEN Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Turning positive |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
PGEN’s outlook is generally improving, supported by an expected return to profitability.
PGEN PE Valuation
This table applies PGEN's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
PGEN Earnings Per Share
This chart tracks PGEN's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
PGEN Quarterly Revenue
This chart tracks PGEN's quarterly revenue over time and shows how sales are changing from year to year.
PGEN Free Cash Flow
This chart tracks PGEN's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
PGEN Total Shares
This chart tracks changes in PGEN's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
PGEN Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
PGEN PE vs Healthcare Sector
This chart compares PGEN's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
PGEN Weekly Price
This chart uses PGEN's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
PGEN Weekly Moving Averages
This chart compares PGEN's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
PGEN Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
UNH
UNH's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins.
UNH vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 24x | 23x | 8% higher+8% |
| PE percentile | 71 | 50 | 42% higher+42% |
| EPS | $15.55 | $18.67 | 17% lower-17% |
| FCF | $23.6B | $21.7B | 9% higher+9% |
| Loading historical comparisons… | |||
UNH’s fundamentals are mixed relative to their historical averages, while its earnings multiple is higher.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Stable |
| Forward profitability | Expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Moderate |
UNH’s outlook is generally improving, with growth expectations supporting the valuation case.
UNH PE Valuation
This table applies UNH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
UNH Earnings Per Share
This chart tracks UNH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
UNH Quarterly Revenue
This chart tracks UNH's quarterly revenue over time and shows how sales are changing from year to year.
UNH Free Cash Flow
This chart tracks UNH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
UNH Total Shares
This chart tracks changes in UNH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
UNH Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
UNH PE vs Healthcare Sector
This chart compares UNH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
UNH Weekly Price
This chart uses UNH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
UNH Weekly Moving Averages
This chart compares UNH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
UNH Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.